Quest Diagnostics Incorporated (DGX)
NYSE·Healthcare·Medical - Diagnostics & Research
$194.94
-0.85%
Mkt Cap $22.69B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 21, 2026 | $2.83B | $2.90B | +2.35% | $2.37 | $2.50 | +5.49% | — | — |
| Q1 2026 Feb 10, 2026 | $2.75B | $2.81B | +1.88% | $2.36 | $2.42 | +2.54% | — | — |
| Q4 2025 Oct 21, 2025 | $2.74B | $2.82B | +2.94% | $2.50 | $2.60 | +4.00% | — | — |
| Q3 2025 Jul 22, 2025 | $2.73B | $2.76B | +1.32% | $2.57 | $2.62 | +1.95% | — | — |
| Q2 2025 Apr 22, 2025 | $2.63B | $2.65B | +0.83% | $2.15 | $2.21 | +2.79% | — | — |
| Q1 2025 Jan 30, 2025 | $2.58B | $2.62B | +1.65% | $2.19 | $2.23 | +1.83% | — | — |
| Q4 2024 Oct 22, 2024 | $2.43B | $2.49B | +2.31% | $2.26 | $2.30 | +1.77% | — | — |
| Q3 2024 Jul 23, 2024 | $2.39B | $2.40B | +0.29% | $2.34 | $2.35 | +0.43% | — | — |
| Q2 2024 Apr 23, 2024 | $2.29B | $2.37B | +3.46% | $1.86 | $2.04 | +9.68% | — | — |
| Q1 2024 Feb 1, 2024 | $2.25B | $2.29B | +1.54% | $2.11 | $2.15 | +1.90% | — | — |
| Q4 2023 Oct 24, 2023 | $2.27B | $2.29B | +0.98% | $2.19 | $2.22 | +1.37% | — | — |
| Q3 2023 Jul 26, 2023 | $2.25B | $2.34B | +3.72% | $2.27 | $2.30 | +1.32% | — | — |
| Q2 2023 Apr 27, 2023 | $2.20B | $2.33B | +6.07% | $1.97 | $2.04 | +3.55% | — | — |
| Q1 2023 Feb 2, 2023 | $2.26B | $2.33B | +3.37% | $1.90 | $1.98 | +4.21% | — | — |
| Q4 2022 Oct 20, 2022 | $2.35B | $2.49B | +5.91% | $2.19 | $2.36 | +7.76% | — | — |
| Q3 2022 Jul 21, 2022 | $2.34B | $2.45B | +4.77% | $2.29 | $2.36 | +3.06% | — | — |
| Q2 2022 Apr 21, 2022 | $2.64B | $2.61B | -1.01% | $2.97 | $3.22 | +8.42% | — | — |
| Q1 2022 Feb 3, 2022 | $2.68B | $2.74B | +2.56% | $3.18 | $3.33 | +4.72% | — | — |
| Q4 2021 Oct 21, 2021 | $2.34B | $2.77B | +18.67% | $2.88 | $3.96 | +37.50% | — | — |
| Q3 2021 Jul 22, 2021 | $2.25B | $2.55B | +13.19% | $2.87 | $3.18 | +10.80% | — | — |